Skip to main content
Premium Trial:

Request an Annual Quote

HiberGene Meningitis Test Gets CE Mark

NEW YORK (GenomeWeb) – Hibergene said last week that it has received CE marking for its HG Meningococcus Direct CSF test and launched it.

The test leverages loop mediated isothermal amplification technology and enables the rapid detection of Neisseria meningitidis, a leading cause of bacterial meningitis, directly from cerebrospinal fluid samples in less than 50 minutes. It can detect all known Neisseria meningitidis serogroups, including A, B, C, 29E, W135, X, Y, and Z at low levels with high accuracy, the Dublin-based firm said in a statement.

"HiberGene is building a portfolio of rapid molecular tests for a range of life-threatening diseases that are capable of saving lives and reducing healthcare costs," HiberGene CEO Brendan Farrell said in a statement, adding the development of the HG Meningococcus Direct CSF test "demonstrates how advances in technology can provide clinically important results in a matter of minutes to deliver significant improvements in patient care." 

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.